Evidence map›Paper›PMID 36348031›Full record

ArticleVirchows Archiv : an international journal of pathology2023

Cauda equina neuroendocrine tumors show biological features distinct from other paragangliomas and visceral neuroendocrine tumors.

Jiri Soukup, Monika Manethova, Ales Kohout, Tomas Soukup, Radka Dvorakova, Jan Drugda, Barbora Vitovcova, Filip Gabalec, Miroslav Kaiser, Martin Kanta and 10 more

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 2 countries.

Jiri SoukupThe Fingerland Department of Pathology, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Sokolska 581, 500 05, Hradec Kralove, Czech Republic. 2jiri.soukup@gmail.com.ORCID http://orcid.org/0000-0001-7169-4386
Monika ManethovaThe Fingerland Department of Pathology, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Sokolska 581, 500 05, Hradec Kralove, Czech Republic.
Ales KohoutThe Fingerland Department of Pathology, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Sokolska 581, 500 05, Hradec Kralove, Czech Republic.
Tomas SoukupDepartment of Histology and Embryology, Faculty of Medicine in Hradec Králové, Charles University, Hradec Kralove, Simkova 870, 500 03, Hradec Kralove, Czech Republic.
Radka DvorakovaDepartment of Radiology, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Sokolska 581, 500 05, Hradec Kralove, Czech Republic.
Jan Drugda4th Department of Internal Medicine, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Sokolska 581, 500 05, Hradec Kralove, Czech Republic.
Barbora VitovcovaDepartment of Medical Biology and Genetics, Faculty of Medicine in Hradec Králové, Charles University, Hradec Kralove, Czech Republic.
Filip Gabalec4th Department of Internal Medicine, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Sokolska 581, 500 05, Hradec Kralove, Czech Republic.
Miroslav KaiserDepartment of Neurosurgery, The Pardubice Region Hospital, a.s., Kyjevska 44, 53203, Pardubice, Czech Republic.
Martin KantaDepartment of Neurosurgery, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Sokolska 581, 500 05, Hradec Kralove, Czech Republic.
Petra KasparovaThe Fingerland Department of Pathology, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Sokolska 581, 500 05, Hradec Kralove, Czech Republic.
Jan KozakDepartment of Neurosurgery, Faculty of Medicine Comenius University and University Hospital Bratislava, Bratislava, Slovakia.
Ludmila MichnovaDepartment of Pathology, Military University Hospital Prague, Prague, Czech Republic.
David NetukaDepartment of Neurosurgery and Neurooncology, 1st Faculty of Medicine, Charles University, Military University Hospital Prague, Prague, Czech Republic.
Stefan ReguliDepartment of Neurosurgery, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
Boris RychlyUnilabs sro., Bratislava, Polianky 7, 84101, Bratislava, Slovak Republic.
Marketa TrnkovaAeskuLab Patologie k.s., Prague, Czech Republic.
Petr VachataDepartment of Neurosurgery, Masaryk Hospital, J. E. Purkyne University, Ustı nad Labem, Czech Republic.
Maria WozniakovaDepartment of Pathology, University Hospital Ostrava and Faculty of Medicine, University of Ostrava, Ostrava, Czech Republic.
Tomas CesakDepartment of Neurosurgery, Charles University, Faculty of Medicine in Hradec Králové and University Hospital Hradec Králové, Sokolska 581, 500 05, Hradec Kralove, Czech Republic.
Charles University · CZUniversity of Ostrava · CZAeskuLab (Czechia) · CZMilitary University Hospital Prague · CZPardubice RegionUniversity Hospital Bratislava · SK

Funding

BBMRI-CZ LM2018125Ministerstvo Zdravotnictví Ceské Republiky NV19-01-00435Univerzita Karlova v Praze Cooperatio Program, research area DIAG
6 · The paper itself

Abstract

Cauda equina neuroendocrine tumors (CENETs) are neoplasms of uncertain histogenesis with overlapping features between those of paragangliomas (PGs) and visceral neuroendocrine tumors (NETs). We have explored their biological relationship to both subsets of neuroendocrine neoplasms. The clinical and radiological features of a cohort of 23 CENETs were analyzed. A total of 21 cases were included in tissue microarrays, along with a control group of 38 PGs and 83 NETs. An extensive panel of antibodies was used to assess epithelial phenotype (cytokeratins, E-cadherin, EpCAM, Claudin-4, EMA, CD138), neuronal and neuroendocrine features (synaptophysin, chromogranin A, INSM1, neurofilaments, NeuN, internexin-α, calretinin), chromaffin differentiation (GATA3, Phox2b, tyrosine hydroxylase), and possible histogenesis (Sox2, T-brachyury, Oct3/4, Sox10). The cohort included 5 women (22%) and 18 men (78%). The average age at the time of surgery was 48.3 years (range from 21 to 80 years). The average diameter of the tumors was 39.27 mm, and invasion of surrounding structures was observed in 6/21 (29%) tumors. Follow-up was available in 16 patients (median 46.5 months). One tumor recurred after 19 months. No metastatic behavior and no endocrine activity were observed. Compared to control groups, CENETs lacked expression of epithelial adhesion molecules (EpCAM, CD138, E-cadherin, Claudin-4), and at the same time, they lacked features of chromaffin differentiation (GATA3, Phox2b, tyrosine hydroxylase). We observed no loss of SDHB. Cytokeratin expression was present in all CENETs. All the CENETs showed variable cytoplasmic expression of T-brachyury and limited nuclear expression of Sox2. These findings support the unique nature of the neoplasm with respect to NETs and PGs.

Indexed as

Cauda EquinaCentral Nervous System NeoplasmsNeuroendocrine TumorsParagangliomaClaudin-4Epithelial Cell Adhesion MoleculeFemaleHumansNeoplasm Recurrence, LocalRepressor ProteinsTranscription FactorsTyrosine 3-MonooxygenaseClaudin-4Epithelial Cell Adhesion MoleculeINSM1 protein, humanRepressor ProteinsTranscription FactorsTyrosine 3-MonooxygenaseCauda equinaImmunohistochemistryNeuroendocrine tumorsParagangliomasSox2

Identifiers

PMID36348031
OpenAlexW4308528744

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.